Revvity, Inc. (RVTY) は上場企業です ヘルスケア セクターの Medical - Diagnostics & Research 業界で事業展開. 本社所在地は Waltham, MA, アメリカ. 現CEOは Prahlad R. Singh.
RVTY を有する IPO日 1965-07-06, 11,000 名の正社員, に上場 NYSE, 時価総額 $10.45B.
Revvity, Inc. is a global provider of products, services, and solutions serving the diagnostics, life sciences, and applied services markets. Operating through two primary segments, Discovery & Analytical Solutions and Diagnostics, the company offers a comprehensive portfolio including analytical instruments, reagents, software, and imaging technologies for research and industrial applications across pharmaceuticals, environmental monitoring, food production, and chemical analysis. The Diagnostics segment specializes in instruments and assay platforms for genetic disorder detection, infectious disease testing, and genomic workflows, serving pharmaceutical companies, biotechnology firms, laboratories, academic institutions, and healthcare organizations worldwide. Founded in 1937 and headquartered in Waltham, Massachusetts, Revvity rebranded from PerkinElmer, Inc. in April 2023 to reflect its evolved market positioning and capabilities.
